Page last updated: 2024-11-01

ondansetron and Brown Tendon Sheath Syndrome

ondansetron has been researched along with Brown Tendon Sheath Syndrome in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"We treated a patient who developed transient multifocal encephalopathy with extrapyramidal symptoms (oromandibular dystonia, oculogyric crisis, and limb dystonia) in temporal proximity to ondansetron administration on emergence from general anesthesia."3.72Ondansetron-induced multifocal encephalopathy. ( Goodman, BP; Ritter, MJ; Sprung, J; Wijdicks, EF, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Macachor, JD1
Kurniawan, M1
Loganathan, SB1
Ritter, MJ1
Goodman, BP1
Sprung, J1
Wijdicks, EF1

Other Studies

2 other studies available for ondansetron and Brown Tendon Sheath Syndrome

ArticleYear
Ondansetron-induced oculogyric crisis.
    European journal of anaesthesiology, 2014, Volume: 31, Issue:12

    Topics: Administration, Intravenous; Adult; Anti-Anxiety Agents; Female; Humans; Ocular Motility Disorders;

2014
Ondansetron-induced multifocal encephalopathy.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:9

    Topics: Antiemetics; Brain Diseases; Dystonia; Female; Hand; Humans; Mandible; Middle Aged; Mouth; Ocular Mo

2003